By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Swedish Orphan Biovitrum 


  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a



Company News
Biogen (BIIB) And Swedish Orphan Biovitrum Receive Positive Opinion From CHMP For Elocta (Rfviiifc) For The Treatment Of Hemophilia A 9/25/2015 9:07:38 AM
Selexis SA Announces Service Agreement With Swedish Orphan Biovitrum 9/22/2015 9:29:09 AM
Swedish Orphan Biovitrum Release: Kineret Receives Australian Regulatory Approval For Use In Systemic Juvenile Idiopathic Arthritis 8/19/2015 9:54:45 AM
Swedish Orphan Biovitrum Release: Results From B-YOND Study Reinforce Long-Term Clinical Profile Of Alprolix For The Treatment Of Haemophilia B 8/18/2015 9:31:17 AM
Swedish Orphan Biovitrum Exercises Opt-In Right For Alprolix 7/16/2015 9:59:07 AM
Swedish Orphan Biovitrum Publishes Its Report For The Second Quarter 2015 - Raises Guidance 7/16/2015 9:47:51 AM
Swedish Orphan Biovitrum Release: European Commission (EC) Approves Orfadin Oral Suspension 6/29/2015 10:32:52 AM
Swedish Orphan Biovitrum Release: New Haemophilia Data At ISTH Congress To Highlight Extension Study Outcomes And Paediatric Use 6/18/2015 10:11:58 AM
Swedish Orphan Biovitrum Board Of Directors Terminates Discussions Regarding Non-Binding Proposal 6/8/2015 9:08:15 AM
Swedish Orphan Biovitrum's Partner Biogen (BIIB) Submits Marketing Authorisation Application For Alprolix (Rfixfc) In Europe 6/4/2015 8:47:23 AM